4.6 Article

The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis

期刊

PLOS MEDICINE
卷 10, 期 6, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pmed.1001474

关键词

-

资金

  1. ENGAGE (European Network for Genetic and Genomic Epidemiology) Consortium
  2. European Community [201413, CEED3 223211, LSHM-CT-2006-037593]
  3. Academy of Finland [104781, 120315, 129418, 139635, 141054]
  4. Center of Excellence in Complex Disease Genetics [213506, 129680]
  5. SALVE research program [129418, 129494]
  6. Australian National Health and Medical Research Council [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498]
  7. Australian Research Council [A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921]
  8. Avera Institute, Sioux Falls, South Dakota (USA)
  9. Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL) [184.021.007]
  10. Biotechnology and Biological Sciences Research Council (BBSRC)
  11. British Heart Foundation
  12. Center for Medical Systems Biology (CSMB, NWO Genomics)
  13. Center of Excellence in Genomics (EXCEGEN)
  14. Chronic Disease Research Foundation (CDRF)
  15. City of Malmo
  16. Crafoord Foundation
  17. Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre
  18. Development Fund of University of Tartu (SP1GVARENG)
  19. Diabetes Programme at the Lund University
  20. Erasmus MC
  21. Erasmus University Rotterdam
  22. Estonian Government [SF0180142s08]
  23. Estonian Research Roadmap through Estonian Ministry of Education and Research [3.2.0304.11-0312]
  24. Estonian Science Foundation [EstSF ETF9353]
  25. EU [QLG2-CT-2002-01254, EU/QLRT-2001-01254]
  26. EUR Fellowship
  27. European Commission (EURO-BLCS) [QLG1-CT-2000-0164, FP6 STRP 018947, LSHG-CT-2006019473]
  28. European Foundation for the Study of Diabetes (EFSD)
  29. European Science Council (ERC) [230374]
  30. European Science Foundation (ESF) [EU/QLRT-2001-01254]
  31. European Union [EU/WLRT-2001-01254]
  32. EUROSPAN (European Special Populations Research Network)
  33. Faculty of Medicine, Lund University
  34. Fellowship Schemes NBIC/BioAssist/RK [2008.024]
  35. Finnish Diabetes Research Society
  36. Finnish Foundation for Cardiovascular Research
  37. Folkhalsan Research Foundation
  38. Foundation for Life and Health in Finland
  39. Foundation for the US National Institutes of Health
  40. French Institute of Health and Medical Research [U258]
  41. Genetic Association Information Network (GAIN)
  42. German Federal Ministry of Education and Research (BMBF)
  43. German National Genome Research Network (NGFNPlus) [01GS0834]
  44. German Research Center for Environmental Health
  45. Guide Dogs for the blind Association(GDBA)
  46. Health Administration of Regione Lombardia [9783/1986, 41795/1993, 31737/1997, 17155/2004]
  47. Health Informatics Centre
  48. Helmholtz Zentrum Munchen
  49. High Performance Computing Center of University of Tartu
  50. International Agency for Research on Cancer
  51. Internationale Stichting Alzheimer Onderzoek (ISAO)
  52. Jakobstad Hospital
  53. K Medical Research Council
  54. Knut and Alice Wallenberg Foundation
  55. LMUinnovativ
  56. Manpei Suzuki Diabetes Foundation
  57. Medical Research Council, UK [G0500539, G0600705]
  58. Medical Society of Finland
  59. Ministry of Education, Culture and Science, The Netherlands
  60. Ministry of Health Welfare and Sports, The Netherlands
  61. Munich Center of Health Sciences (MC Health)
  62. Municipality of Rotterdam
  63. National Cancer Institute [N01-RC-37004]
  64. My Europia Research Training Network
  65. National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit
  66. National Health and Medical Research Council (NHMRC)
  67. National Eye Institute via an NIH/CIDR genotyping project [R01EY018246-01-1]
  68. National Institute of Aging (NIA)
  69. Netherlands Brain Foundation (HersenStichting Nederland)
  70. Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]
  71. Netherlands Genomics Initiative (NGI)
  72. Netherlands Heart Foundation
  73. Netherlands Organization for Health Research and Development (ZonMw) [10-000-1002, 904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717]
  74. Netherlands Organization for Scientific Research (NWO) [175.010.2005.011, 911-03-012, 918-76-619, 916.12.154, Addiction-31160008, Middelgroot-911-09-032, Spinozapremie 56-464-14192]
  75. Netherlands Scientific Organization [904-61-090, 904-61-193, 480-04-004, 400-05717, I 480-05-003]
  76. Neuroscience Campus Amsterdam (NCA)
  77. NHLBI [5R01HL087679-02]
  78. Novo Nordisk Foundation
  79. Narpes Research Foundation
  80. Ollqvist Foundation
  81. Pfizer Global Research Awards for Nicotine Dependence (GRAND)
  82. Pfizer Pharmaceuticals
  83. Pahlsson Foundation
  84. Region Skane
  85. Research Institute for Diseases in the Elderly [014-93-015, RIDE, RIDE2]
  86. Royal Swedish Academy of Sciences
  87. Rutgers University Cell and DNA Repository [NIMH U24 MH068457-06]
  88. Seventh Framework Programme ENGAGE project [HEALTH-F4-2007-201413]
  89. Signe and Ane Gyllenberg Foundation
  90. Sigrid Juselius Foundation
  91. STAMPEED program [1RL1MH083268-01]
  92. Swedish Cancer Society
  93. Swedish Cultural Foundation in Finland
  94. Swedish Diabetes Foundation
  95. Swedish Diabetes Research Society
  96. Swedish Foundation for Strategic Research (SSF) [ICA08-0047]
  97. Swedish Heart and Lung Foundation
  98. Swedish Medical Research Council
  99. Swedish Ministry for Higher Education
  100. Swedish Research Council for Medicine and Health [349-2008-6589, Exodiab 2009-1039, M-2005-1112, 2009-2298]
  101. Swedish Research Council for Infrastructures
  102. Swedish Society of Medicine
  103. US NIH [AA07535, AA10248, AA11998, AA13320, AA13321, AA13326, AA14041, AA15416, AA17688, DA12854, MH66206, R01D0042157-01A, AG028555, AG08724, AG04563, AG10175, AG08861, R01HL089650-02, DK U01-066134, 5R01MH63706: 02, RO1 MH059160, 1RC2MH089951-01]
  104. University Hospital Oulu
  105. University of Dundee
  106. University of Ulm
  107. Uppsala University
  108. Uppsala University Hospital
  109. US National Heart, Lung and Blood Institute
  110. US Public Health Service
  111. Vasa and Narpes Health centers
  112. Wellcome Trust
  113. Wellcome Trust Sanger Institute
  114. VU University's Institute for Health and Care Research (EMGO+)
  115. Swedish Foundation for Strategic Research (SSF) [ICA08-0047] Funding Source: Swedish Foundation for Strategic Research (SSF)
  116. Academy of Finland (AKA) [129418] Funding Source: Academy of Finland (AKA)
  117. British Heart Foundation [PG/09/023/26806] Funding Source: researchfish
  118. Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish
  119. Medical Research Council [G0801056, G0801056B, G0600705, G0902313, MC_UU_12013/1] Funding Source: researchfish
  120. National Institute for Health Research [SRF/01/010, NF-SI-0611-10099] Funding Source: researchfish
  121. Novo Nordisk Fonden [NNF12OC1016467] Funding Source: researchfish
  122. ESRC [ES/G007438/1] Funding Source: UKRI
  123. MRC [G0902313, MC_UU_12013/1, G0801056, G0600705] Funding Source: UKRI

向作者/读者索取更多资源

Background: The association between adiposity and cardiometabolic traits is well known from epidemiological studies. Whilst the causal relationship is clear for some of these traits, for others it is not. We aimed to determine whether adiposity is causally related to various cardiometabolic traits using the Mendelian randomization approach. Methods and Findings: We used the adiposity-associated variant rs9939609 at the FTO locus as an instrumental variable (IV) for body mass index (BMI) in a Mendelian randomization design. Thirty-six population-based studies of individuals of European descent contributed to the analyses. Age-and sex-adjusted regression models were fitted to test for association between (i) rs9939609 and BMI (n = 198,502), (ii) rs9939609 and 24 traits, and (iii) BMI and 24 traits. The causal effect of BMI on the outcome measures was quantified by IV estimators. The estimators were compared to the BMI-trait associations derived from the same individuals. In the IV analysis, we demonstrated novel evidence for a causal relationship between adiposity and incident heart failure (hazard ratio, 1.19 per BMI-unit increase; 95% CI, 1.03-1.39) and replicated earlier reports of a causal association with type 2 diabetes, metabolic syndrome, dyslipidemia, and hypertension (odds ratio for IV estimator, 1.1-1.4; all p<0.05). For quantitative traits, our results provide novel evidence for a causal effect of adiposity on the liver enzymes alanine aminotransferase and gamma-glutamyl transferase and confirm previous reports of a causal effect of adiposity on systolic and diastolic blood pressure, fasting insulin, 2-h post-load glucose from the oral glucose tolerance test, C-reactive protein, triglycerides, and high-density lipoprotein cholesterol levels (all p<0.05). The estimated causal effects were in agreement with traditional observational measures in all instances except for type 2 diabetes, where the causal estimate was larger than the observational estimate (p = 0.001). Conclusions: We provide novel evidence for a causal relationship between adiposity and heart failure as well as between adiposity and increased liver enzymes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据